HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for hemophilia a enters human safety testing
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 men with hemophilia A. The main goal is to see if different doses are safe. Participants will take the medicine by mouth and be monitored for about 11 weeks. This is an early-stage trial, so Inno8 is not yet availa…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
New study tracks Real-World use of clotting factor in hemophilia a patients
Disease control Recruiting nowThis study observes how well Octapharma's FVIII concentrates (Nuwiq, Octanate, Wilate) work in real life for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding events and side effects over time. The goal is to understand the…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for hemophilia: can SCT800 stop bleeds before they start?
Disease control Recruiting nowThis study tests a new medicine called SCT800 in 36 men with severe hemophilia A who have never been treated with factor VIII before. The goal is to see if regular infusions of SCT800 can safely prevent bleeding episodes. Participants will receive the drug on a schedule and be mo…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
Personalized immune therapy shows promise in hemophilia a patients
Disease control Recruiting nowThis study looks at how well a personalized, high-dose immune tolerance therapy works in 300 hemophilia A patients who have developed inhibitors (antibodies that block treatment). The therapy uses specially selected clotting factor concentrates to try to restore the body's abilit…
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Real-World use of a clotting factor drug in iraqi hemophilia patients under review
Knowledge-focused Recruiting nowThis study observes how turoctocog alfa, a clotting factor medicine, is actually used in routine care for people with hemophilia A in Iraq. Researchers will review medical records from about 900 male patients to track bleeding rates and treatment patterns. The study does not chan…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 17, 2026 11:38 UTC
-
Breakthrough study reveals best time to eat for new hemophilia drug
Knowledge-focused Recruiting nowThis study tests a new medicine called Inno8 for hemophilia A. It looks at how eating and drinking before and after taking the pill changes how much medicine gets into the blood. 80 healthy men aged 18-45 will take a single dose after fasting, then fast again for different length…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC